Safety Study of Fenofibrate During Pregnancy

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2024

Study Completion Date

December 1, 2025

Conditions

Severe Hypertriglyceridemia During Pregnancy

Interventions

DRUG

Fenofibrate

Fenofibrate is orally administrated daily with food for at least 1 week during pregnancy

Trial Locations (1)

RECRUITING

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors

lead

First People's Hospital of Hangzhou

OTHER